1. bookVolume 26 (2018): Issue 3 (July 2018)
Journal Details
License
Format
Journal
eISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
access type Open Access

Biomarkers in Obesity

Published Online: 31 Jul 2018
Page range: 353 - 358
Received: 03 Apr 2018
Accepted: 08 Jul 2018
Journal Details
License
Format
Journal
eISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English

1. Han JC, Lawlor DA, Kimm YS. Childhood Obesity. Lancet. 2010;375(9727):1737-48. DOI: 10.1016/S0140-6736(10)60171-710.1016/S0140-6736(10)60171-7Open DOISearch in Google Scholar

2. De Onis M, Blossner M, Borghi E. Global prevalence and trends of overweight and obesity among preschool children. Am J Clin Nutr. 2010;92(5):1257–64. DOI: 10.3945/ajcn.2010.2978610.3945/ajcn.2010.29786Open DOISearch in Google Scholar

3. Chirita-Emandi A, Barbu CG, Cinteza EE, Chesaru BI, Gafencu M, Mocanu V, et al. Overweight and Under-weight Prevalence Trends in Children from Romania – Pooled Analysis of Cross-Sectional Studies between 2006 and 2015. Obes Facts. 2016;9(3):2016-20. DOI: 10.1159/00044417310.1159/000444173Open DOISearch in Google Scholar

4. NCD Risk Factor Collaboration (NCD-RisC). Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: a pooled analysis of 1018 population-based measurement studies with 88.6 million participants. Int J Epidemiol. 2018;0:1–21 in press.Search in Google Scholar

5. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, over-weight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627-2642. DOI: 10.1016/S0140-6736(17)32129-310.1016/S0140-6736(17)32129-3Open DOISearch in Google Scholar

6. Bray GA, Heisel WE, Afshin A, Jensen MD, Dietz WH, Long M et al. The Science of Obesity Management: an Endocrine Society Scientific Statement. Endocr Rev 2018;39:1-54. DOI: 10.1210/er.2017-0025310.1210/er.2017-00253Open DOISearch in Google Scholar

7. Levy E, Saenger AK, Steff MW, Delvin E. Pediatric Obesity and Cardiometabolic Disorders: Risk Factors and Biomarkers. EJIFCC 2017;28(1):6-24.Search in Google Scholar

8. Zhu ZL, Yang QM, Li C, Chen J, Xiang M, Chen MM et al. Identification of biomarkers for childhood obesity based on expressional correlation and functional similarity. Mol Med Rep. 2018;17(1):109-16.Search in Google Scholar

9. Sikaris KA. The Clinical Biochemistry of Obesity. Clin Biochem Rev. 2004;25(3):165-81.Search in Google Scholar

10. Socha P, Hellmuth C, Gruszfeld D, Demmelmair H, Rzehak P, Grote V, et al. Endocrine and Metabolic Biomarkers Predicting Early Childhood Obesity Risk. Nestle Nutr Inst Workshop Ser. 2016;85:81-8. DOI: 10.1159/00043948910.1159/000439489Search in Google Scholar

11. Cinteza M - Can we Cure Type 2 Diabetes Mellitus? Maybe Yes !...- Maedica (Bucharest). 2013 Sep;8(3):229-30.Search in Google Scholar

12. Venner AA, Lyon ME, Doyle-Baker PK. Leptin: a Potential Biomarker for Childhood Obesity? Clin Biochem. 2006 Nov;39(11):1047-56. DOI: 10.1016/j.clinbiochem.2006.07.01010.1016/j.clinbiochem.2006.07.010Open DOISearch in Google Scholar

13. Yigitbasi T, Baskin Y, Akgol E, Kocal GC, Ellidokuz H. Association of ischemia-modified albumin with oxidative stress status and insulin resistance in obese patients. Rev Romana Med Lab. 2017;25(3):255-63. DOI: 10.1515/rrlm-2017-002010.1515/rrlm-2017-0020Open DOISearch in Google Scholar

14. Sandor R, Leucuta D, Dronca E, Niculae A, Cret V, Silaghi C, et al. Low Serum Paraoxonase-1 Lactonase and Arylesterase Activities in Obese Children and Adolescents. Rev Romana Med Lab. 2015;23(4):385-95. DOI: 10.1515/rrlm-2015-003810.1515/rrlm-2015-0038Open DOISearch in Google Scholar

15. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care 2018 Jan;41(Suppl 1):S1-S151.10.2337/dc18-Sint01Search in Google Scholar

16. Cornell S. Comparison of the diabetes guidelines from the ADA/EASD and the AACE/ACE. J Am Pharm Assoc (2003). 2017 Mar - Apr;57(2):261-265.10.1016/j.japh.2016.11.005Search in Google Scholar

17. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyper-glycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015 Jan;38(1):140-9. DOI: 10.2337/dc14-244110.2337/dc14-2441Open DOISearch in Google Scholar

18. Garvey WT, Ryan DH, Bohannon NJ, Kushner RF, Rueger M, Dvorak RV, et al. Weight-loss therapy in type 2 diabetes: effects of phentermine and topiramate extended release. Diabetes Care. 2014 Dec;37(12):3309-16. DOI: 10.2337/dc14-093010.2337/dc14-0930Open DOISearch in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo